R&D How labs can lead the way in sustainability Through focused strategies and industry collaboration, labs can significantly reduce waste, energy usage, and emissions.
Sales & Marketing The hidden IP problem holding innovators back For organisations active in the US market, the impact of patent marking is financial, not administrative.
R&D The Autumn Budget: What it means for UK life sciences deVere and Inventus comment on the UK Autumn Budget and what it means for life sciences in the country.
News £800m life sciences cluster opens in London In a boost for the UK life sciences sector, a new £800m life sciences hub located at Barts Health NHS Trust in London has been opened today.
News Sofinnova Partners raises €650m for early-stage biotechs European life sciences venture capital company Sofinnova Partners has closed its latest fund, Sofinnova Capital XI, raising €650 million.
News Medicxi raises €500m for latest biotech fund Medicxi closes its fifth round, raising €500m for 'asset-centric' firms at all stages of development and taking the total raised in 10 years to €2bn+.
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
